News & Updates
Filter by Specialty:
Show Multimedia Only

Diabetes does not influence effects of tirzepatide in HFpEF patients with obesity
17 Sep 2025
byStephen Padilla
Patients with heart failure (HF) with preserved ejection fraction (HFpEF), obesity, and type 2 diabetes (T2D) show a favourable response to tirzepatide despite less pronounced weight loss, reports a study.
Diabetes does not influence effects of tirzepatide in HFpEF patients with obesity
17 Sep 2025
What’s hot at APS & MCV 2025?
15 Sep 2025
MIMS Doctor brings you extensive coverage of the Asia Pneumonia Summit & MasterClass in Vaccinology 2025, held recently in Taipei, Taiwan. Check out the latest updates on RSV, pneumococcal disease, new vaccines, plus thought-provoking insights from respiratory experts. [READ THE FULL REPORT]